AR020064A1 - Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion. - Google Patents
Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion.Info
- Publication number
- AR020064A1 AR020064A1 ARP990101558A ARP990101558A AR020064A1 AR 020064 A1 AR020064 A1 AR 020064A1 AR P990101558 A ARP990101558 A AR P990101558A AR P990101558 A ARP990101558 A AR P990101558A AR 020064 A1 AR020064 A1 AR 020064A1
- Authority
- AR
- Argentina
- Prior art keywords
- dorsalization
- elaboration
- combination
- pharmaceutical composition
- composition containing
- Prior art date
Links
- 230000002138 osteoinductive effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 230000022159 cartilage development Effects 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
Composicion farmacéutica que contiene una combinacion de una proteína osteoinductora y un factor de dorsalizacion en una relacion de 10:1 a 1:10, es unagente farmacéutico de utilidad para la condrogénesis, y método para su elaboracion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98106404A EP0950414A1 (en) | 1998-04-08 | 1998-04-08 | Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction |
Publications (1)
Publication Number | Publication Date |
---|---|
AR020064A1 true AR020064A1 (es) | 2002-04-10 |
Family
ID=8231737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990101558A AR020064A1 (es) | 1998-04-08 | 1999-04-06 | Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0950414A1 (es) |
JP (1) | JP2000053579A (es) |
KR (1) | KR19990082999A (es) |
CN (1) | CN1236645A (es) |
AR (1) | AR020064A1 (es) |
AU (1) | AU2359099A (es) |
BR (1) | BR9903179A (es) |
CA (1) | CA2267844A1 (es) |
TR (1) | TR199900748A2 (es) |
ZA (1) | ZA992570B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002366974A1 (en) * | 2001-12-27 | 2003-07-30 | Gbf-Gesellschaft Fur Biotechnologische Forschung Gmbh | Methods of inducing or enhancing connective tissue repair |
WO2005032578A1 (en) | 2003-10-06 | 2005-04-14 | Monash University | Therapeutic method |
WO2012029148A1 (ja) * | 2010-09-01 | 2012-03-08 | 株式会社オステオファーマ | 組換えヒト骨形成タンパク質-2凍結乾燥製剤 |
CN107913436A (zh) * | 2016-10-09 | 2018-04-17 | 刘英芹 | 作用于伤残组织原位的骨与软组织同步再生诱导剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE355369T1 (de) * | 1993-10-14 | 2006-03-15 | Harvard College | Verfahren zur induzierung und zur erhaltung neuronalen zellen |
US5846770A (en) * | 1994-11-22 | 1998-12-08 | Genetics Institute, Inc. | DNA molecules encoding human chordin |
-
1998
- 1998-04-08 EP EP98106404A patent/EP0950414A1/en not_active Withdrawn
-
1999
- 1999-03-31 CA CA002267844A patent/CA2267844A1/en not_active Abandoned
- 1999-04-06 AU AU23590/99A patent/AU2359099A/en not_active Abandoned
- 1999-04-06 CN CN99104920A patent/CN1236645A/zh active Pending
- 1999-04-06 AR ARP990101558A patent/AR020064A1/es unknown
- 1999-04-06 TR TR1999/00748A patent/TR199900748A2/xx unknown
- 1999-04-07 BR BR9903179-5A patent/BR9903179A/pt not_active Application Discontinuation
- 1999-04-07 ZA ZA9902570A patent/ZA992570B/xx unknown
- 1999-04-07 KR KR1019990011994A patent/KR19990082999A/ko not_active Application Discontinuation
- 1999-04-08 JP JP11101262A patent/JP2000053579A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TR199900748A2 (xx) | 1999-10-21 |
CN1236645A (zh) | 1999-12-01 |
BR9903179A (pt) | 2000-05-09 |
ZA992570B (en) | 1999-10-08 |
AU2359099A (en) | 1999-10-21 |
JP2000053579A (ja) | 2000-02-22 |
EP0950414A1 (en) | 1999-10-20 |
CA2267844A1 (en) | 1999-10-08 |
KR19990082999A (ko) | 1999-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI973828L (fi) | Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi | |
ES2144192T3 (es) | Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
YU49315B (sh) | Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje | |
PT747050E (pt) | Composicoes farmaceuticas que contem irbesartan | |
ID29393A (id) | Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah | |
YU53098A (sh) | Preparat koncentrovanog antitela | |
BR9509710A (pt) | Composições para hemorróidas e método de uso | |
ATE247470T1 (de) | Neue substituierte imidazolverbindungen | |
EE9900410A (et) | Koostised ja meetodid silmasisese rõhu alandamiseks | |
TR200100922T2 (tr) | Aktif maddelerin akciğerler yolu ile tatbik edilmesi. | |
EE9800136A (et) | Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine | |
PT998272E (pt) | Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol | |
GT199700009A (es) | Terapia combinada para la osteoporosis. | |
PT777482E (pt) | Composicao de combinacao para utilizacao em doencas imunologicas | |
FI971536A0 (fi) | Keratinosyytti-kasvutekijän analogeja | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
ES2132556T3 (es) | Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen. | |
ECSP941120A (es) | Derivados de 1,5 benzodiazepina | |
AR010636A1 (es) | COMPOSICION BIOCIDA ALQUIDICA, CONCENTRADO DE LA MISMA, FORMULACIoN DE RECUBRIMIENTO Y MÉTODO PARA ESTABILIZAR LA ACTIVIDAD BIOCIDA. | |
BR9706902A (pt) | Uso de pelo menos um inibidor da atividade do ácido retinóico e composição | |
AR020064A1 (es) | Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion. | |
ES2120667T3 (es) | Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis. | |
FI964113L (fi) | Lääkekoostumus hoitamaan tardiivia dyskinesiaa ja sen käyttö | |
EA200000112A1 (ru) | Новая композиция | |
ES2155187T3 (es) | Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos. |